ERIBULINE BAXTER 0,44 mg/mL, solution injectable — 1 flacon unidose en verre de 2 mL

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930295922
  • CIP7 3029592
  • CIS 64894431
  • Registration number EU/1/24/1819

What the source publishes

Holder
BAXTER HOLDING (PAYS-BAS)
Active ingredients
ÉRIBULINE, MÉSILATE D'ÉRIBULINE
Form
solution injectable
Package
1 flacon unidose en verre de 2 mL
Routes
intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2024-06-27
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930295922
{
  "cis": "64894431",
  "cip7": "3029592",
  "form": "solution injectable",
  "name": "ERIBULINE BAXTER 0,44 mg/mL, solution injectable — 1 flacon unidose en verre de 2 mL",
  "cip13": "3400930295922",
  "holder": "BAXTER HOLDING (PAYS-BAS)",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "BAXTER HOLDING (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2024-06-27",
  "compositions": [
    {
      "name": "ÉRIBULINE",
      "nature": "FT",
      "strength": "0,44 mg",
      "linkageNumber": "1",
      "substanceCode": "21374",
      "dosageReference": "1 mL de solution",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "MÉSILATE D'ÉRIBULINE",
      "nature": "SA",
      "strength": "0,5 mg",
      "linkageNumber": "1",
      "substanceCode": "67656",
      "dosageReference": "1 mL de solution",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ERIBULINE BAXTER 0,44 mg/mL, solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon unidose en verre de 2 mL",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-01-22",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ÉRIBULINE",
    "MÉSILATE D'ÉRIBULINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/24/1819",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930295922"